EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC 3.0

Programmed Death-Ligand 1 Expression across Multiple Assays in Ovarian Cancer: A Comparative Analysis

Eun Bi Jang, Kyeong A So, Wook Youn Kim, So Dug Lim, Tae Jin Kim, Heejin Bang, Wan Seop Kim

Cancer Research and Treatment · 15.04.2026 · 58 (2) · 622-631

DOI: 10.4143/crt.2025.202 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Cancer Research and Treatment, erschienen am 15.04.2026. Verfasst von Eun Bi Jang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Research Institute of Medical Science, Konkuk University School of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: B7-H1 Antigen, Ovarian Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Korea Health Industry Development Institute, Ministry of Health and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PurposeOvarian cancer presents significant treatment challenges due to its aggressive nature and poor response to immune checkpoint inhibitors (ICIs). The lack of standardized programmed cell death-ligand 1 (PD-L1) assays and cut-off values complicates clinical decision-making. We evaluated the concordance among commonly used PD-L1 assays and assessed changes in the expression of PD-L1 following chemotherapy.Materials and MethodsTissue samples from 29 patients with ovarian cancer were analyzed using five validated PD-L1 immunohistochemistry assays: Dako 22C3, Ventana SP263, Ventana SP142, Dako 28-8, and Ventana 22C3. PD-L1 positivity was assessed using a combined positive score (CPS), immune cell, or tumor proportion score at 1%, 5%, and 10% cut-offs. Concordance rates, including overall percent agreement and Cohen’s kappa coefficient, were analyzed. In addition, changes in the expression of PD-L1 pre- and postchemotherapy were evaluated.ResultsPositivity rates ranged from 15.8% (SP142) to 29.8% (Dako 22C3 and SP263) at the 1% CPS cut-off. SP142 consistently exhibited the lowest concordance, whereas Dako 22C3 displayed high agreement with SP263, 28-8, and Ventana 22C3. Chemotherapy increased PD-L1 positivity, with 28% of patients converting from negative to positive.ConclusionThe expression of PD-L1 in ovarian cancer varies across assays and scoring methods, emphasizing the need for standardized testing protocols. Increased PD-L1 expression post-chemotherapy underscores the importance of assessing its status at appropriate times to guide ICI therapy. Larger studies are required to validate these findings and refine clinical applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B7-H1 AntigenOvarian NeoplasmsBiomarkers, TumorHumansFemaleMiddle AgedImmunohistochemistryAgedAdultImmune Checkpoint InhibitorsAged, 80 and over

Stichwörter der Autor:innen

Immune checkpoint inhibitorsImmunohistochemistryOvarian neoplasmsProgrammed cell death ligand 1 (PD-L1)

Substanzen

B7-H1 AntigenCD274 protein, humanBiomarkers, TumorImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Research Institute of Medical Science, Konkuk University School of Medicine, Seoul, Korea.
  • Department of Pathology, Research Institute of Medical Science, Konkuk University School of Medicine, Seoul, Korea.

Förderung

  • Korea Health Industry Development Institute
  • Ministry of Health and Welfare

Zitieren

APA

Jang, E. B., So, K. A., Kim, W. Y., Lim, S. D., Kim, T. J., Bang, H., & Kim, W. S. (2026). Programmed Death-Ligand 1 Expression across Multiple Assays in Ovarian Cancer: A Comparative Analysis. Cancer Research and Treatment, 58(2), 622-631. https://doi.org/10.4143/crt.2025.202

Vancouver

Jang EB, So KA, Kim WY, Lim SD, Kim TJ, Bang H, et al. Programmed Death-Ligand 1 Expression across Multiple Assays in Ovarian Cancer: A Comparative Analysis. Cancer Research and Treatment. 2026;58(2):622-631. doi:10.4143/crt.2025.202

BibTeX
@article{Jang2026,
  author = {Jang, Eun Bi and So, Kyeong A and Kim, Wook Youn and Lim, So Dug and Kim, Tae Jin and Bang, Heejin and Kim, Wan Seop},
  title = {Programmed Death-Ligand 1 Expression across Multiple Assays in Ovarian Cancer: A Comparative Analysis},
  journal = {Cancer Research and Treatment},
  year = {2026},
  volume = {58},
  number = {2},
  pages = {622--631},
  doi = {10.4143/crt.2025.202}
}
Kostenlos starten →